Program
We designed the conference to give all attendees an opportunity to meet with presenters. The agenda begins with a welcome from host Mike Powell, Ph.D., General Partner of Sofinnova Ventures, followed by sessions from the presenting companies. The schedule below will be completed in the coming months as we finalize all presenting companies. Please check back to find an updated agenda.
| October 4th, 2011 | Track A (Nami) | Track B (Nagisa) |
|---|---|---|
| 8:00 a.m. – 9:00 a.m. | Breakfast and Registration | |
| 9:00 a.m. – 9:15 a.m. | Welcome (Nami) Garheng Kong, M.D., Ph.D., General Partner, Sofinnova Ventures | |
|
9:15 a.m. 9:35 a.m. 9:55 a.m. 10:15 a.m. 10:35 a.m. |
Aerie CoLucid Pharmaceuticals Euthymics Biosciences Intra-Cellular Therapies | Auspex Pharmaceuticals Catalyst Biosciences CureVac Domain Therapeutics Anaphore |
| 10:55 a.m. – 11:10 a.m. | Break & Networking | |
|
11:10 a.m. 11:30 a.m. 11:50 p.m. 12:10 p.m. 12:30 p.m. |
NeuroTherapeutics Chimerix Tragara Pharmaceuticals Cebix Neurocrine Biosciences |
MacroGenics Noxxon Open Monoclonal Technology GlycoVaxyn Liquidia Technologies |
| 12:50 p.m. – 1:20 p.m. | Lunch & Networking | |
| 1:20 p.m. – 1:30 p.m. | Remarks (Nami) John Craighead Ph.D., Managing Director, Investor Relations and Business Development, Biotechnology Industry Organization | |
| 1:30 p.m. – 2:30 p.m. | Lunch Panel (Nami) Moderator Christopher Hite, Managing Director, Global Head of Healthcare, Citi Group Panelists Ken Araki, Senior Director, Corporate Strategic & Planning Dept., Takeda Pharmaceutical David Kabakoff Ph.D., Executive Partner, Sofinnova Ventures Dennis Podlesak, Partner, Domain Associates Jennifer Jarrett, Managing Director, Citigroup Makiko Yukawa, Managing Director, Citigroup Global Markets Japan |
|
|
2:30 p.m. 2:50 p.m. 3:10 p.m. 3:30 p.m. 3:50 p.m. |
Ardelyx Lithera Sorbent Therapeutics Trius Therapeutics Asmacure |
Cardeus Pharmaceuticals Regado Biosciences DBV Technologies Flexion Therapeutics Durata Therapeutics |
| 4:10 p.m. – 4:25 p.m. | Break & Networking | |
|
4:25 p.m. 4:45 p.m. 5:05 p.m. 5:25 p.m. 5:45 p.m. | Hutchison MediPharma Intellikine Mersana Sunesis Pharmaceuticals Syndax Pharmaceuticals | Achillion Pharmaceuticals Cempra Pharmaceuticals Tranzyme Tobira Therapeutics Rib-X Pharmaceuticals |
| 6:00 p.m. – 8:00 p.m. | Cocktail Reception (Nagi) Remarks by David Collier, M.D., Managing Director, CMEA Capital | |